Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 733-744

  Chen, Cyndi ^a   Lee, Wen Hui ^a   Yun, Pen ^a   Snow, Peter ^b   Liu, Chih Pin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE DERIVATIVE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; CELL COMMUNICATION; CELL ISOLATION; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETOGENESIS; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE; TH2 CELL;

EID: 0038783708     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.733     Document Type: Article

References (59)

1. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727.
2. Tian, J., A. P. Olcott, L. R. Hanssen, D. Zekzer, B. Middleton, and D. L. Kaufman. 1998. Infectious Th1 and Th2 autoimmunity in diabetes-prone mice. Immunol. Rev. 164:119.
3. Nepom, G. T., and W. W. Kwok. 1998. Molecular basis for HLA-DQ associations with IDDM. Diabetes 47:1177.
4. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5:601.
5. Bach, J. F., and L. Chatenoud. 2001. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:131.
6. Mathis, D., L. Vence, and C. Benoist. 2001. beta-Cell death during progression to diabetes. Nature 414:792.
7. McDevitt, H. 2001. The role of MHC class II molecules in the pathogenesis and prevention of type I diabetes. Adv. Exp. Med. Biol. 490:59.
8. Gottlieb, P. A., and G. S. Eisenbarth. 2002. Insulin-specific tolerance in diabetes. Clin. Immunol. 102:2.
9. Falcone, M., and N. Sarvetnick. 1999. The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Clin. Immunol. 90:2.
10. Cooke, A., J. M. Phillips, and N. M. Parish. 2001. Tolerogenic strategies to halt or prevent type 1 diabetes. Nat. Immunol. 2:810.
11. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
12. Tian, J., M. Clare-Salzler, A. Herschenfeld, B. Middleton, D. Newman, R. Mueller, S. Arita, C. Evans, M. A. Atkinson, Y. Mullen, et al. 1996. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1348.
13. Cetkovic-Cvrlji, M., I. C. Gerling, A. Muir, M. A. Atkinson, J. F. Elliott, and E. H. Leiter. 1997. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 46:1975.
14. Tisch, R., B. Wang, and D. V. Serreze. 1999. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163:1178.
15. Quinn, A., B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, and E. E. Sercarz. 2001. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decorboxylase and use distinct Vβ genes. J. Immunol. 166:2982.
16. Tisch, R., B. Wang, M. A. Atkinson, D. V. Serreze, and R. Friedline. 2001. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice. J. Immunol. 166:6925.
17. Pakala, S. V., M. O. Kurrer, and J. D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreafitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299.
18. Poulin, M., and K. Haskins. 2000. Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse. J. Immunol. 164:3072.
19. Kappos, L., G. Comi, H. Panitch, J. Oger, J. Antel, P. Conlon, and L. Steinman. 2000. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial: The altered peptide ligand in relapsing MS study group. Nat. Med. 6:1176.
20. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen specific T lymphocytes. Science 274:94.
21. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity 8:675.
22. Liu, C. P., K. Jiang, C. H. Wu, W. H. Lee, and W. J. Lin. 2000. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers. Proc. Natl. Acad. Sci. USA 97:14596.
23. You, Y., C. Chen, W. H. Lee, C.-H. Wu, V. Judkowski, C. Pinilla, B. Wilson, and C.-P. Liu. 2003. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J. Immunol. 170:4011.
24. Haskins, K., and D. Wegmann. 1996. Diabetogenic T cell clones. Diabetes 45:1299.
25. + Thl cells induce diabetes in NOD/SCD mice. J. Clin. Invest. 101:68.
26. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74:1089.
27. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson. 2001. Identification of MHC class II-restricted pepfide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908.
28. Scott, C. A., K. C. Garcia, F. R. Carbone, I. A. Wilson, and L. Teyton. 1996. Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules. J. Exp. Med. 183:2087.
29. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:2736.
30. + T-cells from rat spleen. J. Immunol. Methods 244:29.
31. Chao, C. C., and H. O. McDevitt. 1997. Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46:29.
32. Chao, C. C., H. K. Sytwu, E. L. Chen, J. Toma, and H. O. McDevitt. 1999. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Proc. Natl. Acad. Sci. USA 96:9299.
33. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
34. Viner, N. J., C. A. Nelson, B. Deck, and E. R. Unanue. 1996. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156:2365.
35. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737.
36. + islet-specific T cell clone. Science 249:1433.
37. Shevach, E. M. 2000. Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 18:423.
38. Sakaguchi, S. 2000. Animal models of autoimmunity and their relevance to human diseases. Curr. Opin. Immunol. 12:684.
39. Roncarolo, M. G., and M. K. Levings. 2000. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12:676.
40. Maloy, K. J., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immunol. 2:816.
41. + T cells. J. Exp. Med. 188:1849.
42. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629.
43. Egen, J. G., M. S. Kuhns, and J. P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3:611.
44. + T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J. Exp. Med. 196:481.
45. Cottrez, F., S. D. Hurst, R. L. Coffman, and H. Groux. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:4848.
46. Hsieh, C. S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713.
47. Forsthuber, T., H. C. Yip, and P. V. Lehmann. 1996. Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728.
48. Carrasco-Marin, E., O. Kanagawa, and E. R. Unanue. 1997. Insights into the chemistry and biology of the I-Ag7 class II molecule. Res. Immunol. 148:291.
49. Corper, A. L., T. Stratmann, V. Apostolopoulos, C. A. Scott, K. C. Garcia, A. S. Kang, I. A. Wilson, and L. Teyton. 2000. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288:505.
50. Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, and D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12:699.
51. Piganelli, J. D., T. Martin, and K. Haskins. 1998. Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 47:1212.
52. Noorchashm, H., D. J. Moore, L. E. Noto, N. Noorchashm, A. J. Reed, A. L. Reed, H. K. Song. R. Mozaffari, A. M. Jevnikar, C. F. Barker, and A. Naji. 2000. Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J. Immunol. 165:4685.
53. Wang, B., A. Gonzalez, P. Hoglund, J. D. Katz, C. Benoist, and D. Mathis. 1998. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47:1207.
54. Serreze, D. V., H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352.
55. Flaishon, L., I. Topilski, D. Shoseyov, R. Hershkoviz, E. Fireman, Y. Levo, S. Marmor, and I. Shachar. 2002. Anti-inflammatory properties of low levels of IFN-γ. J. Immunol. 168:3707.
56. Lee, M. S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.
57. + T cells in autoimmune diabetes. Nat. Immunol. 2:1117.
58. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877.
59. + suppressor T cells: more questions than answers. Nat. Immunol. 2:389.